Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Xencor, Inc.
Xencor, Inc.
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
University of Colorado, Denver
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center
University of Nebraska
Imperial College London
Var2 Pharmaceuticals
University of Pittsburgh
University of Calgary
Washington University School of Medicine
Travera Inc
A2 Biotherapeutics Inc.
Centre Hospitalier de Valence
University of Florida
Apollomics Inc.
ModeX Therapeutics, An OPKO Health Company
Columbia University
Stanford University
Northwestern University
European Organisation for Research and Treatment of Cancer - EORTC